InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Clene Inc.

CLNN Clue Score16
United States Fiscal year ends December CIK 0001822791
$3.86 -0.52% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.86 −39.78% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 31 Dec 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Operating income−16.3Net income−16.2Fiscal year 2020Revenue0.2Operating income−20.2Net income−19.3Fiscal year 2021Revenue0.7 +251.0%Operating income−50.0Net income−9.7Fiscal year 2022Revenue0.5 −34.6%Operating income−48.4Net income−29.9Fiscal year 2023Revenue0.7 +38.3%Operating income−40.5Net income−49.5Fiscal year 2024Revenue0.3 −47.7%Operating income−33.1Net income−39.4Fiscal year 2025Revenue0.2 −41.5%Operating income−23.1Net income−26.2
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 0.2 0.7 0.5 0.7 0.3 0.2
Growth +251.0% −34.6% +38.3% −47.7% −41.5%
Operating income −16.3 −20.2 −50.0 −48.4 −40.5 −33.1 −23.1
Net income −16.2 −19.3 −9.7 −29.9 −49.5 −39.4 −26.2
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2019Fiscal year 2020Operating margin−9,812.6%Net margin−9,357.8%Free cash flow margin−9,376.7%Fiscal year 2021Operating margin−6,912.6%Net margin−1,347.2%Free cash flow margin−4,973.2%Fiscal year 2022Operating margin−10,234.5%Net margin−6,325.2%Free cash flow margin−9,342.5%Fiscal year 2023Operating margin−6,198.8%Net margin−7,569.4%Free cash flow margin−4,663.8%Fiscal year 2024Operating margin−9,676.3%Net margin−11,520.5%Free cash flow margin−6,240.1%Fiscal year 2025Operating margin−11,541.5%Net margin−13,086.5%Free cash flow margin−9,292.5%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a −9,812.6% −6,912.6% −10,234.5% −6,198.8% −9,676.3% −11,541.5%
Net margin n/a −9,357.8% −1,347.2% −6,325.2% −7,569.4% −11,520.5% −13,086.5%
Free cash flow margin n/a −9,376.7% −4,973.2% −9,342.5% −4,663.8% −6,240.1% −9,292.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−13.2Capital expenditure−0.3Free cash flow−13.5Fiscal year 2020Operating cash flow−18.9Capital expenditure−0.4Free cash flow−19.3Fiscal year 2021Operating cash flow−34.6Capital expenditure−1.3Free cash flow−36.0Fiscal year 2022Operating cash flow−39.0Capital expenditure−5.2Free cash flow−44.2Fiscal year 2023Operating cash flow−30.2Capital expenditure−0.3Free cash flow−30.5Fiscal year 2024Operating cash flow−21.3Capital expenditure−0.0Free cash flow−21.3Fiscal year 2025Operating cash flow−18.5Capital expenditure−0.0Free cash flow−18.6
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −13.2 −18.9 −34.6 −39.0 −30.2 −21.3 −18.5
Capital expenditure −0.3 −0.4 −1.3 −5.2 −0.3 −0.0 −0.0
Free cash flow −13.5 −19.3 −36.0 −44.2 −30.5 −21.3 −18.6
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2019Cash8.8Shareholders’ equity−67.8Fiscal year 2020Cash59.3Total debt5.9Net cash (debt)53.4Shareholders’ equity0.3Debt to equity17.37Fiscal year 2021Cash50.3Shareholders’ equity12.6Fiscal year 2022Cash18.3Shareholders’ equity3.2Fiscal year 2023Cash28.8Shareholders’ equity13.4Fiscal year 2024Cash12.2Shareholders’ equity−8.9Fiscal year 2025Cash5.2Total debt17.8Net cash (debt)−12.6Shareholders’ equity−17.6
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 8.8 59.3 50.3 18.3 28.8 12.2 5.2
Total debt n/a 5.9 n/a n/a n/a n/a 17.8
Net cash (debt) n/a 53.4 n/a n/a n/a n/a −12.6
Shareholders’ equity −67.8 0.3 12.6 3.2 13.4 −8.9 −17.6
Debt to equity n/a 17.37 n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
8.8 59.3 50.3 18.3 28.8 12.2 5.2
n/a 0.0 0.0 0.2 0.1 0.1 0.0
0.0 0.2 0.0 0.0 0.0 0.1 0.0
4.3 4.2 5.2 n/a n/a n/a n/a
14.9 68.2 63.1 44.5 52.3 27.3 18.1
Growth +358.7% −7.6% −29.4% +17.6% −47.8% −33.7%
Liabilities
n/a 5.9 n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a 17.8
calc n/a 5.9 n/a n/a n/a n/a 17.8
10.0 67.9 50.5 41.3 39.0 36.2 35.7
Equity
−69.6 −153.6 −163.3 −193.2 −242.7 −282.1 −308.3
−67.8 0.3 12.6 3.2 13.4 −8.9 −17.6
Growth +3,594.1% −74.3% +313.7% −166.1%
Per share and net cash
calc n/a 53.4 n/a n/a n/a n/a −12.6
17.4 59.5 62.3 74.8 6.4 8.1 10.8
calc −3.90 0.01 0.20 0.04 2.09 −1.09 −1.62

Lines marked calc are worked out here from filed figures; point at one for how.